Ellington Management Group’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Ellington Management Group’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6,300	Closed	-$552K	–	506
2020 Q1	$552K	Buy	+6,300	New	+$667K	0.13%	234
2019 Q4	–	Sell	-5,500	Closed	-$633K	–	819
2019 Q3	$633K	Buy	+5,500	New	+$835K	0.11%	184
2018 Q4	–	Sell	-2,900	Closed	-$501K	–	667
2018 Q3	$501K	Buy	+2,900	New	+$418K	0.13%	202
2018 Q1	–	Sell	-10,400	Closed	-$1.37M	–	1087
2017 Q4	$1.37M	Buy	+10,400	New	+$1.22M	0.22%	55

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ellington Management Group's GWPH Position: Q2 2020 in Review

Ellington Management Group sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2020, closing a stake of 6,300 shares — an estimated $552K sold.

Ellington Management Group first reported a position in GWPH in Q4 2017 and held it in 4 quarters. The position peaked at $1.37M in Q4 2017. 299 funds tracked by Wall St. Rank hold GWPH as of Q2 2020.

Ellington Management Group reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2020 after selling out during the quarter.
Ellington Management Group sold 6,300 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2020, an estimated $552K.
Ellington Management Group first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2017 and held it in 4 quarters.
Ellington Management Group's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.37M in Q4 2017.
299 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2020.

Based on Ellington Management Group's 13F filing for Q2 2020, filed 17 Aug 2020.